Skip to content
Search

Latest Stories

'False fears' about vaping stopping smokers using e-cigs: PHE

More than half of UK smokers now wrongly believe that nicotine-containing "vapes" or e-cigarettes are as dangerous as tobacco cigarettes and these "false fears" are preventing smokers from switching, public health experts said on Wednesday.

In a report commissioned by Public Health England (PHE), scientists at King's College London said the mistaken belief that e-cigarettes are more harmful than smoking had gained ground rapidly following thousands of reported cases of lung injury in the United States in late 2019.


But the belief is "out of line" with expert reviews from Britain and the United States concluding that using regulated nicotine vaping products is far less harmful than smoking, they said.

The report, the sixth by PHE on the issue of e-cigarettes, is likely to deepen divisions in opinion about the potential risks of the products.

The U.S. Centers for Disease Control and Prevention said last month it had recorded more than 2,800 cases of lung injury linked to vaping.

"It is concerning to see how much the U.S. lung disease outbreak has affected smokers' views on e-cigarettes here in the UK," said John Newton, director of health improvement at PHE.

"Safety fears may well be deterring many smokers from switching, leaving them on a path to years of ill health and an early death due to their smoking," he said.

Health authorities in the United States have said that vitamin E acetate, a thickening agent added to cannabis vaping products, is the likely primary cause of the U.S. outbreak.

The substance is banned from UK-regulated nicotine vapes and e-cigarettes.

The PHE report reiterated the agency's view that "e-cigarettes are much less harmful than tobacco but are not completely safe".

"They contain significantly less harmful chemicals which cause diseases related to smoking but the long-term impact of using e-cigarettes will remain unknown for some time," PHE said in a summary of the report.

It added that any British move to ban the use of flavours in regulated vaping products, as the U.S. and other countries have done, would deter smokers from switching and would "ultimately cost lives".

The U.S. government has proposed a sweeping ban on all vaping flavours that are seen as attracting young users. The PHE cautioned against any similar move in Britain, saying it would deter smokers from switching and would "ultimately cost lives".

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less